Sat.Jan 22, 2022 - Fri.Jan 28, 2022

Merck drug for chronic cough rejected by FDA

Bio Pharma Dive

According to the drugmaker, the FDA asked in a complete response letter for more information related to how the drug's efficacy was measured

Drugs 232

The downside of VC funding for biotech

World of DTC Marketing

Venture capitalists have poured $42 billion into drug development over the past three years. Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? not necessarily.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Feelings of fatigue predict death in older adults

Scienmag

PITTSBURGH, Jan. 24, 2022 – How fatigued certain activities make an older person feel can predict the likelihood death is less than three years away, according to research published today in the Journal of Gerontology: Medical Sciences by University of Pittsburgh epidemiologists.

Chronic kidney disease: treating a silent killer

Pharma Phorum

In November, NICE backed NHS use of AstraZeneca’s diabetes and heart failure drug Forxiga for the treatment of chronic kidney disease. pharmaphorum caught up with AZ’s Joris Silon to discuss unmet needs in the condition.

Drugs 97

Lessons in Supply Chain Digitization from PepsiCo and Conagra

Speaker: Craig Weiss, ConAgra Brands; Mari Roberts PepsiCo; and Matt Elenjickal, FourKites

Supply chain digitalization is key to success as market volatility, widespread disruption & stiff competition for consumer dollars puts pressure on every aspect of the supply chain. Register to hear how 2 global brands are accelerating digital transformation and increasing efficiency & automation throughout their operations.

US turns to Gilead's COVID-19 drug to help counter omicron

Bio Pharma Dive

With other COVID treatments ineffective against the variant or in short supply, the FDA is expanding its approval of Veklury to include outpatient use

Drugs 222

The biggest transformation in pharma marketing since DTC

World of DTC Marketing

This is an exciting time to be in healthcare marketing. We’re witnessing the most significant transformation in healthcare marketing since DTC was approved in the ’90s.

More Trending

IBM sells off large parts of Watson Health business

Pharma Phorum

A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis.

3 ways an IWMS can help streamline your manufacturing operations

Bio Pharma Dive

Manage, maintain and optimize all the tasks, duties and goals that fall under the umbrella of your workplace

The era of “consumer healthcare”?

World of DTC Marketing

Clunky, costly, highly regulated health systems, often dominated by rent-seeking middlemen, are being shaken up by firms that target patients directly, meet them where they are—which is increasingly online—and give them more control over how to access care.

A virtual reality ‘Shopping Task’ could help test for cognitive decline in adults

Scienmag

3 Ways End-to-End Visibility Helps Minimize the Risks of Ocean Freight

Download this playbook to learn how end-to-end visibility helps to mitigate risk associated with the ocean freight market.

The Mid-Atlantic Region and Philadelphia Chapter of the Healthcare Businesswomen’s Association Announces their 2022 HBA Master Class Series

Pharma Marketing Network

In partnership with Villanova University, Drexel University, Thomas Jefferson University, the University of the Sciences and Columbia Business School, the HBA continues to advocate for the connection between advanced education and advancement in the workplace.

Iowa's institutions on the leading edge of next-gen vaccines and therapies

Bio Pharma Dive

Learn more about Iowa's efforts in the ongoing fight against pandemics and other threats to human and animal health

Epizyme Announces Pricing of Public Offering of Common Stock

BioTech 365

Epizyme Announces Pricing of Public Offering of Common Stock Epizyme Announces Pricing of Public Offering of Common Stock CAMBRIDGE, Mass.–(BUSINESS –(BUSINESS WIRE)–Epizyme, Inc.

Kirigami robotic grippers are delicate enough to lift egg yolks

Scienmag

Engineering researchers from North Carolina State University have demonstrated a new type of flexible, robotic grippers that are able to lift delicate egg yolks without breaking them, and that are precise enough to lift a human hair.

4 Silver Linings of the Chaotic Ocean Freight Market

Speaker: Peter Tirschwell, Chris Stauber, Sarah Barnes Humphrey, and Audrey Ross

Join this webinar exploring the silver linings that have emerged from the chaotic ocean freight market. The discussion will highlight solutions that prioritize digitization and build a more efficient international supply chain. Jan 25 at 10am CT.

What to Do When a Debt Collector Contacts You

Triage Cancer

Dealing with debt can feel overwhelming, but knowing what to do when a debt collector contacts you is important. Medical bills, credit card bills, student loans, and other types of debt are often sent to a “collection agency,” which then becomes responsible for collecting payment from you.

52

Gene editing startup Metagenomi raises $175M to advance research pipeline

Bio Pharma Dive

The biotech raised the Series B round during "probably one of the worst biotech markets" emerging drugmakers have faced in some time, a Metagenomi executive told BioPharma Dive

Taysha Gene Therapies Announces Positive Initial Biomarker Data For TSHA-101, the First Bicistronic Gene Therapy in Clinical Development, Demonstrating Normalization of β-Hexosaminidase A Enzyme Activity in Patients With GM2 Gangliosidosis

BioTech 365

Taysha Gene Therapies Announces Positive Initial Biomarker Data For TSHA-101, the First Bicistronic Gene Therapy in Clinical Development, Demonstrating Normalization of ?-Hexosaminidase

Finding the tipping point for coastal wetlands

Scienmag

DURHAM, N.C. — The Albemarle-Pamlico Peninsula covers more than 2,000 square miles on the North Carolina coastal plain, a vast expanse of forested swamps and tea-colored creeks.

82

The Smart Data Revolution: How AB InBev Drives Efficiency with Visibility Data

Speaker: AB InBev and FourKites

Register for our upcoming webinar to learn how leveraging the right data to make quick, well-informed decisions is the key to success in supply chain & logistics. Join FourKites and AB InBev to learn what’s possible with a data-driven supply chain strategy & real-time transportation visibility.

FDA approves IND for clinical trial evaluating CBD-based drug

Outsourcing Pharma

The agency has given the go-ahead on an IND application for a study evaluating Ananda Scientificâs Nantheia ATL5, a candidate for treating opioid use disorder. Clinical Development

A biotech wins the first FDA drug approval in a rare type of eye cancer

Bio Pharma Dive

based Immunocore's treatment, known as Kimmtrak, is also the first T cell receptor drug to have reached market in the U.S. so far

Sierra Oncology to Present at B. Riley Securities Oncology Investor Conference

BioTech 365

Sierra Oncology to Present at B. Riley Securities Oncology Investor Conference Sierra Oncology to Present at B. Riley Securities Oncology Investor Conference SAN MATEO, Calif.–(BUSINESS –(BUSINESS WIRE)–Sierra Oncology, Inc.

52

The Work of the Future: Building Better Jobs in an Age of Intelligent Machines

Scienmag

“For too long, American workers have been left behind. Business leaders have a responsibility to their workers to understand the challenges and opportunities associated with building better jobs.

Modernizing Pharmaceutical Supply Chains

Speaker: Nimesh Patel, Gregory Demitrack, and Sarah Barnes Humphrey

Register for our upcoming webinar to better understand the state of the pharmaceutical supply chain. FourKites partnered with Accenture to survey supply chain executives working in pharmaceuticals, biotech, cell and gene therapy, medtech, and other related industries.

Pfizer starts dosing patients with its Omicron COVID shot

Pharma Phorum

Pfizer and partner BioNTech have started their clinical trial of a new version of their COVID-19 vaccine that has been specifically designed to protect against the Omicron variant.

Atara sells cell therapy plant to Fujifilm for $100M

Bio Pharma Dive

The site, which specializes in manufacturing off-the-shelf immunotherapies, was once a key asset for Atara. New owner Fujifilm will still supply the biotech under a long-term agreement

Allay Therapeutics Appoints Ron Burch, M.D., Ph.D. to Scientific Advisory Board

BioTech 365

Allay Therapeutics Appoints Ron Burch, M.D., to Scientific Advisory Board Allay Therapeutics Appoints Ron Burch, M.D., to Scientific Advisory Board MENLO PARK, Calif.–(BUSINESS

A soft, stretchable thermometer

Scienmag

The next generation of soft robotics, smart clothing and biocompatible medical devices are going to need integrated soft sensors that can stretch and twist with the device or wearer.

Minimizing Retail Supply Chain Disruptions in 2021 and Beyond

Speaker: Izaac Moran, Customer Success Manager, FourKites; Glenn Koepke, SVP of Customer Success, FourKites; and featuring interviews with supply chain experts from Dollar Tree and Best Buy

Register for our upcoming webinar to see how savvy retailers including Dollar Tree and Best Buy are leveraging real-time visibility across their end-to-end supply chains in creative ways to drive agility and thrive in today’s unpredictable environment.

Wageningen University, VectorY team up to develop next gen AAV expression systems

BioPharma Reporter

Netherlands-based gene therapy company, VectorY Therapeutics, and Wageningen University have signed a strategic collaboration agreement for the development of novel baculovirus-based AAV production technologies. Bio Developments

Paul Stoffels, J&J's former top scientist, to lead Galapagos

Bio Pharma Dive

Stoffels, who helped build Galapagos in its early days, is now taking helm of the biotech as it looks to recover from a recent series of setbacks

New patent expiration for Genentech Inc drug ESBRIET

Drug Patent Watch

Annual Drug Patent Expirations for ESBRIET Esbriet is a drug marketed by Genentech Inc and is included in two NDAs. It is available from one supplier. There are twenty-one patents….

Current vaccines teach T cells to fight Omicron

Scienmag

LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have found that four COVID-19 vaccines (Pfizer-BioNTech, Moderna, J&J/Janssen, and Novavax) prompt the body to make effective, long-lasting T cells against SARS-CoV-2.

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.